HIND – vyome holdings, inc. (US:NASDAQ)
Stock Stats
News
Vyome Files for VT-1953 Orphan Drug Status, Furthers Strategic Focus On VT-1953 Program Over the Next 6 Months
Vyome Successfully Capitalizes All VT-1953 Funding Requirements For Initial Phase 3 Results
Independent Analyst Values Vyome’s VT-1953 at USD 1 Billion Upon Successful Completion of Phase 3 Study
Vyome (NASDAQ:HIND) had its "sell (e-)" rating reaffirmed by analysts at Weiss Ratings.
We're Not Very Worried About Vyome Holdings' (NASDAQ:HIND) Cash Burn Rate [Yahoo! Finance]
Form 8-K Vyome Holdings, Inc For: Jan 28
Form 8-K Vyome Holdings, Inc For: Dec 17
Form 424B3 Vyome Holdings, Inc
Form 8-K Vyome Holdings, Inc For: Nov 18
Form 4 Vyome Holdings, Inc For: Nov 13 Filed by: Pomichter Stanley D III
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.